Ribonucleotide reductase inhibitor

From Wikipedia, the free encyclopedia

Ribonucleotide reductase inhibitors are a family of anticancer drugs that interfere with the growth of tumor cells by blocking the formation of deoxyribonucleotides (building blocks of DNA).

[edit] External links

This article includes text from the U.S. National Cancer Institute's public domain Dictionary of Cancer Terms